BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1132 related articles for article (PubMed ID: 18819785)

  • 21. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome and its components in men.
    Adriansjah H; Adam JM
    Acta Med Indones; 2005; 37(2):66-70. PubMed ID: 20066787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.
    Sattar N; Williams K; Sniderman AD; D'Agostino R; Haffner SM
    Circulation; 2004 Oct; 110(17):2687-93. PubMed ID: 15492304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.
    Indhavivadhana S; Wongwananuruk T; Rattanachaiyanont M; Techatraisak K; Leerasiri P; Tanmahasamut P; Popijan M
    J Med Assoc Thai; 2010 Jun; 93(6):653-60. PubMed ID: 20572369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
    Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
    Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
    Sirdah MM; Abu Ghali AS; Al Laham NA
    Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
    Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
    Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese.
    Cheung BM; Wat NM; Tam S; Thomas GN; Leung GM; Cheng CH; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Clin Endocrinol (Oxf); 2008 May; 68(5):730-7. PubMed ID: 17980012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probable blind spot in the International Diabetes Federation definition of metabolic syndrome.
    Chen HJ; Pan WH
    Obesity (Silver Spring); 2007 May; 15(5):1096-100. PubMed ID: 17495185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population.
    Strazzullo P; Barbato A; Siani A; Cappuccio FP; Versiero M; Schiattarella P; Russo O; Avallone S; della Valle E; Farinaro E
    Metabolism; 2008 Mar; 57(3):355-61. PubMed ID: 18249207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differing definition-based prevalence of metabolic syndrome in the women of Oman family study: a function of multiparity.
    Al-barwani SA; Bayoumi RA; Jaju D; Al-Yahyaee SA; Al-Hadabi S; Lopez-Alvarenga JC; Comuzzie AG; Hassan MO
    Metab Syndr Relat Disord; 2008 Sep; 6(3):197-202. PubMed ID: 18699722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
    Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
    Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of cardiovascular risk factors in hypertensive subjects with metabolic syndrome defined by three different definitions.
    Shrestha R; Jha SC; Khanal M; Gyawali P; Yadav BK; Jha B
    JNMA J Nepal Med Assoc; 2011; 51(184):157-63. PubMed ID: 22922894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome.
    Benetos A; Thomas F; Pannier B; Bean K; Jégo B; Guize L
    Am J Cardiol; 2008 Jul; 102(2):188-91. PubMed ID: 18602519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions.
    Zabetian A; Hadaegh F; Azizi F
    Diabetes Res Clin Pract; 2007 Aug; 77(2):251-7. PubMed ID: 17234299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Rasmussen S; Ibsen H; Torp-Pedersen C; Madsbad S
    J Am Coll Cardiol; 2007 May; 49(21):2112-9. PubMed ID: 17531661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.